BioLineRx (BLRX) Change in Intangibles (2013 - 2023)

BioLineRx (BLRX) recorded quarterly Change in Intangibles of -$2000.0 in Q4 2023, up 92.31% quarter-over-quarter from -$26000.0 in Q3 2023, and up 98.83% on a YoY basis from -$1005.9 in Q4 2022.

BioLineRx (BLRX) Change in Intangibles (2013 - 2023) Analysis & Trends

BioLineRx's Change in Intangibles history runs 8 years deep, the most recent figure standing at -$2000.0 for Q4 2023.

  • In Q4 2023, Change in Intangibles rose 98.83% year-over-year to -$2000.0; the TTM figure through Dec 2023 stood at -$181000.0 (up 98.22% YoY), while the FY2025 annual figure was -$2000.0, down 100.0% from the prior year.
  • Change in Intangibles was -$2000.0 for Q4 2023 at BioLineRx, up from -$26000.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of -$2000.0 in Q4 2023 to a low of -$171000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.96 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 BioLineRx 227.63 Mn 211.90 Mn 154,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2023 -2,000.00
Dec 31, 2023 -2,000.00
Sep 30, 2023 -26,000.00
Sep 30, 2023 -26,000.00
Jun 30, 2023 -56,000.00
Jun 30, 2023 -56,000.00
Mar 31, 2023 -97,000.00
Mar 31, 2023 -97,000.00
Dec 31, 2022 -171,000.00
Dec 31, 2022 -171,000.00
Sep 30, 2022 -14,000.00
Sep 30, 2022 -14,000.00
Dec 31, 2018 -10.00 Mn
Dec 31, 2018 -10.00 Mn
Sep 30, 2018 -3,000.00
Sep 30, 2018 -3,000.00
Jun 30, 2018 -8,000.00
Jun 30, 2018 -8,000.00
Mar 31, 2018 -29,000.00
Mar 31, 2018 -29,000.00